Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections
Go back to Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections| (NASDAQ: LABT) | Delayed: 2.89 -0.52 (15.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.41 | 52 Week High | $ | |||
| Open | $3.55 | 52 Week Low | $ | |||
| Day High | $3.55 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $ | |||
| Volume | 1,753,933 | |||||
